Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT05988073

A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy

This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. Participants will follow their regular visit schedule with their treating physician, except for an optional second visit occurring 7 to 14 days after the start of the study to collect biomarker data. No IMP will be administered.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Multifocal Motor Neuropathy

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Royal Melbourne Hospital, Parkville, Australia

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Is at least the local legal age of consent for clinical studies when signing the ICF
  • Is capable of providing signed informed consent and complying with protocol requirements
  • Has an existing or new diagnosis of MMN made by a neuromuscular specialist or neurologist

Exclusion criteria

  • Is currently participating in any clinical study with an IMP
  • Has other medical conditions that could affect the assessment of MMN

Treatment and study plan

Primary outcomes

  1. To characterize MMN patient profiles for participants

    Time frame: up to 61 months

  2. To assess the MMN disease management and disease course

    Time frame: up to 61 months

  3. To assess outcome measures specific to MMN disease and their evolution over time

    Time frame: up to 61 months

  4. To estimate the burden of MMN on participants' quality of life

    Time frame: up to 61 months

  5. To estimate the economic burden for participants with MMN

    Time frame: up to 61 months

  6. To collect data on relevant disease biomarkers

    Time frame: up to 61 months

Sponsors and collaborators

Lead sponsor

argenx

Industry

Registry information

Official study title

A Multicenter Prospective Longitudinal Study of Clinical Outcomes, Disease Course, Health-Related Quality of Life, and Health Care Resource Utilization in Adult Patients With Multifocal Motor Neuropathy

Acronym: iMMersioN

Important dates

Study start
2023
Primary completion
2028
Study completion
2028
First posted
Aug 14, 2023
Registry last updated
May 29, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.